Search Results

Filter
  • 10-20 of  18,473 results for ""SCHIZOPHRENIA treatment""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy.

  • Authors : Sapienza J; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Humanities and Life Sciences, University School for Advanced Studies IUSS, Pavia, Italy.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Clozapine*/Clozapine*/Clozapine*/therapeutic use; Humans

  • Source: Schizophrenia research [Schizophr Res] 2024 Feb; Vol. 264, pp. 71-80. Date of Electronic Publication: 2023 Dec 14.Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Potential impact on mental health in patients with treatment-resistant schizophrenia - clozapine augmentation with long-acting parenteral antipsychotics: a case series.

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Clozapine*/Clozapine*/Clozapine*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

  • Source: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti [Ceska Slov Farm] 2024; Vol. 72 (6), pp. 277-287.Publisher: Ceská lékarská spolecnost J. E. Purkyne Country of Publication: Czech Republic NLM ID: 9433765 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Side effects of clozapine in older adults with treatment-resistant schizophrenia compared to younger adults.

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy; Humans

  • Source: International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2024 Jan; Vol. 39 (1), pp. e6051.Publisher: John Wiley Country of Publication: England NLM ID: 8710629 Publication Model: Print Cited Medium: Internet ISSN: 1099-1166

Record details

×
Academic Journal

The longitudinal structure of negative symptoms in treatment resistant schizophrenia.

  • Authors : Wolpe N; Department of Physical Therapy, The Stanley Steyer School of Health Professions, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/complications

  • Source: Comprehensive psychiatry [Compr Psychiatry] 2024 Jan; Vol. 128, pp. 152440. Date of Electronic Publication: 2023 Nov 27.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0372612 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Refractory Schizophrenia: A Randomized Clinical Trial.

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Clozapine*/Clozapine*/Clozapine*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

  • Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Jan-Feb 01; Vol. 44 (1), pp. 9-15.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Short Turnaround of Clozapine Blood Level Results Within 6 hours is Essential for Effective Management of Severely Ill Persons with Treatment-Resistant Schizophrenia.

  • Authors : Vincent PD; Department of Pharmacy, Institut universitaire en santé mentale de Montréal, Montréal, Canada.; Faculty of Pharmacy, Université de Montréal, Montréal, Canada.

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Apr 01; Vol. 46 (2), pp. 274-275. Date of Electronic Publication: 2024 Feb 09.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment-resistant schizophrenia.

  • Authors : Araujo MB; School of Medicine, Federal University of Ceara, Fortaleza, Ceará, Brazil.; Nogueira GN

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use; Humans

  • Source: Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2024 Apr; Vol. 149 (4), pp. 361-362. Date of Electronic Publication: 2024 Jan 23.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370364 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Is ECT better than clozapine for treatment-resistant schizophrenia?

  • Authors : Uppinkudru C; Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India.; Sreeraj VS

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use

  • Source: Asian journal of psychiatry [Asian J Psychiatr] 2023 Dec; Vol. 90, pp. 103798. Date of Electronic Publication: 2023 Oct 11.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101517820 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.

  • Authors : Tsukahara M; Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan.; So R

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use

  • Source: Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2023 Nov; Vol. 148 (5), pp. 437-446. Date of Electronic Publication: 2023 Sep 08.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370364 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Reply to Dr Yucel's Comments on the Article "Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia".

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects

  • Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2023 Nov-Dec 01; Vol. 43 (6), pp. 555-556.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 10-20 of  18,473 results for ""SCHIZOPHRENIA treatment""